Lee Hood, Clayton Lewis, Nathan Price, and more | GenomeWeb

Lee Hood, Clayton Lewis, Nathan Price, and more

Jul 14, 2015

Institute for Systems Biology spinout Arivale has announced its management team and scientific advisory board.

Clayton Lewis is the company's CEO and one of its co-founders. He is also a general partner at Maveron, an Arivale investor. Lee Hood, president of ISB, and Nathan Price, associate director of ISB, are the other company co-founders. Jennifer Lovejoy is Arivale's chief translational science officer. Most recently, she was senior vice president of clinical and quality support at Alere Wellbeing. Sean Bell serves as the company's chief business officer. Previously, he was executive vice president at Free & Clear, a health coaching company.

Arivale's SAB members are chairman Lee Hood, Frances Arnold of the California Institute of Technology, George Church of Harvard Medical School, Robert Green of Brigham and Women's Hospital and Harvard Medical School, Jim Heath of the California Institute of Technology, Ed Lazowska of the University of Washington, Larry Smarr of the University of California San Diego, Ralph Snyderman of Duke University, Bonnie Spring of Northwestern University, and Eric Topol of the Scripps Research Institute.

More Like This

Mar 23, 2017

Michael Hanbury

Acuamark Diagnostics has appointed Michael Hanbury to its board of directors. Hanbury is currently a healthcare advisor for the Pritzker Group and is on a number of medical device company boards. Previously, he served as VP of laboratory operations and laboratory excellence for Quest Diagnostics, and president and chief operating officer at Solstas Lab Partners. Earlier in his career he served as president and CEO of DCL Medical Laboratories, and as executive VP of operations and CSO at Unilab.

Mar 22, 2017

Jerry Williamson

Kew has appointed Jerry Williamson president, CEO, and board member. Williamson most recently served as president and CEO of Metamark Genetics. He has also held senior leadership positions at Flagship Ventures, which was later sold to Danaher; Biacore, which was later sold to GE Life Sciences; and Pyrosequencing.

Mar 22, 2017

Grace Terrell

Envision Genomics has appointed Grace Terrell as founding CEO. Terrell most recently served as the founder and strategist for Cornerstone Health Enablement Strategic Solutions, which she founded in 2012. She concurrently served as CEO of Cornerstone Health Care from 2000 to 2016, and is a practicing internist at Cornerstone Health Care.

Mar 22, 2017

Elizabeth Jaffe

The American Association for Cancer Research has elected Elizabeth Jaffe as its president for 2017-2018. Jaffe is currently a chair and member of the National Cancer Advisory Board for the National Cancer Institute, and co-chair of the NCI Blue Ribbon Panel for the National Cancer Moonshot Initiative. She is also the deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, the associate director of the Bloomberg-Kimmel Institute for Cancer Immunotherapy, professor of oncology and professor of pathology at Johns Hopkins School of Medicine, and an active staff member in oncology at Johns Hopkins Hospital.

Mar 21, 2017

David Heckerman

David Heckerman has joined Human Longevity as chief data scientist. He will report to Co-Founder Craig Venter and will lead a team analyzing large-scale medical and genomic data. Heckerman comes to HLI from Microsoft, where he worked for more than 25 years. He led that company's first research team focused on machine learning and helped produce the first content-based spam filter. More recently, he led Microsoft Genomics, including Microsoft's cloud computing services for genomics. Heckerman has held adjunct faculty and visiting scholar positions at a number of institutions, including the University of California, Los Angeles, the University of Washington, and Columbia University. He holds a medical degree and a doctorate in computer science, both from Stanford University.

Mar 20, 2017

Samraat Raha

Agilent Technologies has named Samraat Raha senior VP of strategy and corporate development. Raha will report directly to Agilent President and CEO Mike McMullen. His duties will include advising the firm's executive team and developing its global growth strategy, including for mergers and acquisitions. Raha joins Agilent from Illumina, where was VP of global marketing. He also served as VP and general manager of genomic assays at Life Technologies, where he helmed the TaqMan and qPCR product lines.

Mar 17, 2017

Kim Popovits, Wendy Yarno

MyoKardia has appointed Kim Popovits and Wendy Yarno to its board of directors. Popovitz currently serves on the boards of the American Clinical Laboratory Association, California Life Sciences Association, Personalized Medicine Coalition, and ZS Pharma. She has served as Genomic Health's CEO and president since 2009, and chairman of the company's board since 2013. Yarno is the non-executive chairman of the board of Aratana Therapeutics and has served on the boards of ADial PHarmaceuticals, Durata Therapeutics, Medivation, St. Jude Medical, and PluroGen Therapeutics. She is also a retired chief marketing officer for Merck.

Mar 15, 2017

Koh Boon Hwee

Agilent Technologies has appointed Koh Boon Hwee as chairman of the board of directors. Boon Hwee has been a member of the company's board since 2003, and replaces James Cullen who served as chairman since 2005. Cullen will continue to serve on the board as a director. Boon Hwee is the managing director of Credence Capital Fund II and serves as the non-executive chairman to Sunningdale Tech. He has previously served as chairman at DBS Bank, Singapore Airlines, and Singapore Telecom.

Mar 15, 2017

George Asimenos, Fan Fan

DNAnexus has appointed George Asimenos to chief technology officer and Fan Fan as vice president of product management. Asimenos has been with DNAnexus since its inception and most recently served as vice president of strategic projects. Prior to DNAnexus, he conducted research at Stanford University and National Technical University of Athens in comparative metagenomics, silicon compilers for reconfigurable hardware, and elliptic curve strypanalysis. Fan joins DNAnexus from Adobe, where she served as principal of product management. Prior to Adobe, she led product management at Model N.

Mar 15, 2017

Seven Bridges Scientific Advisory Board

Seven Bridges has appointed James Knight, Jan Korbel, Charles Lee, Heng Li, Gholson Lyon, and Gokhan Hotamisligil to its newly formed scientific advisory board. Knight is currently the director of bioinformatics and research scientists at The Knight Lab at Yale University. Korbel is the principal investigator and senior scientists at the European Molecular Biology Laboratory in Heidelberg, Germany. Lee is the scientific director and professor at the Jackson Laboratory for Genomic Medicine. Li is a research scientists at the Broad Institute at MIT and Harvard, working with David Reich and David Altshuler to understand the genetic causes of disease. Lyon is the head of Cold Spring Harbor Laboratory's Lyon Lab and a research scientist at the Utah Foundation for Biomedical Research. Hotamisligil is the James S. Simmons professor of genetics and metabolism and chair of the department of genetics and complex diseases at Harvard University's School of Public Health.

Mar 15, 2017

Ken Tarkoff

Syapse has appointed Ken Tarkoff as its CEO. Tarkoff was chief operating officer for RelayHealth and served as senior vice president and general manager of the firm after it was acquired by McKesson. Before his time at RelayHealth, Tarkoff served as director of supplier services at Xign Corporation. He has also served as vice president of product management at Questium and vice president of regional operations at Vivra Specialty Partners.

Mar 15, 2017

Michael Hunter, Mike Falvey, Andrew Gruen, Milan Mitrovic, Bruce Press

Seven Bridges has appointed Michael Hultner as chief strategy officer, Mike Falvey as CFO, Andrew Guren as chief communications officer, Milan Mitrovic as chief product officer, and Bruce Press as executive vice president of business development and strategy. Hultner comes to Seven Bridges from Leidos Health, where he served as chief scientist for Health & Life Sciences. Falvey joins Seven Bridges after working as a CFO in life sciences, high technology, and financial services industries, including Analysis Group, Ahura Scientific, Aspect Medical Systems, and Millennium Pharmaceuticals. Gruen joins Seven Bridges from Northwestern University's Media Management Center, where he served as director of research. Mitrovic previously served as Seven Bridges' senior director of product development. Press comes to Seven Bridges from EMC, where he served as director of big data solutions.

Mar 15, 2017

Brandi Davis-Dusenbery

Seven Bridges has promoted Brandi Davis-Dusenbery to CEO. She succeeds Co-founder Deniz Kural, who is assuming the role of executive chairman of the board of directors. Davis-Dusenbery was the former senior vice president of science and product for Seven Bridges. Prior to Seven Bridges, she worked as a fellow at Harvard University's Department of Stem Cell and Regenerative Biology.

Mar 09, 2017

Dan Szot

Cambridge Semantics has appointed Dan Szot as vice president of sales for the company's life science division. Szot comes to Cambridge Semantics from PerkinElmer, where he served at VP of sales. Prior to PerkinElmer, he served as VP of sales at Biovia.

Mar 08, 2017

Shawn Lynch

Shawn Lynch has resigned from his position as CFO of T2 Biosystems, effective immediately. According to a Form 8K the company filed this week with the US Securities and Exchange Commission, Lynch left for personal reasons and not as the result of a disagreement with management or the board.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.